Stock CLS B CLINICAL LASERTHERMIA SYSTEMS AB
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Clinical Laserthermia Systems AB

Equities

CLS B

SE0022049920

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-06-10 pm EDT 		5-day change 1st Jan Change
6.097 SEK -3.30% Intraday chart for Clinical Laserthermia Systems AB -6.40% -77.91%
May. 31 Clinical Laserthermia Systems to Raise SEK59 Million via Rights Issue MT
May. 29 Clinical Laserthermia Systems AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Clinical Laserthermia Systems to Raise SEK59 Million via Rights Issue
Clinical Laserthermia Systems AB Reports Earnings Results for the First Quarter Ended March 31, 2024
Clinical Laserthermia Systems AB Enters into an Exclusive Distribution Agreement with MTEC Company
Clinical Laserthermia Notes US FDA Clearance for ClearPoint's Prism Bone Anchor Accessory
Clinical Laserthermia Systems AB Presents Initial Data from the Investigator Initiated Trial at Radboud University Medical Center Using the CLS Transberg System
Clinical Laserthermia Systems Receives Second Order from the National Institutes of Health Clinical Center in the US for its TRANBERG Thermal Therapy System Accessories
Clinical Laserthermia Systems AB Announces Two Patients with Localized Prostate Cancer Have Been Safely Treated with the Tranberg Thermal Therapy System At the San Luigi Gonzaga University Hospital in Turin, Italy
Clinical Laserthermia Systems AB's Subsidiary CLS Americas Signs Agreement with ROSE Urology for Treatment of Prostate Cancer Patients with TRANBERG Thermal Therapy System
Clinical Laserthermia Systems Names Interim CFO
Clinical Laserthermia Systems AB Announces Publication of Preclinical Assessment of A Non-Cooled MR Thermometry-Based Neurosurgical Laser Therapy System
Clinical Laserthermia Systems AB Reports Earnings Results for the Full Year Ended December 31, 2023
Clinical Laserthermia Systems AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Clinical Laserthermia Systems Gains Underwriting Commitments for Warrant Series Exercise
Clinical Laserthermia Systems Files Patent Extension, Expansion for Non-cooled Laser Applicators
Clinical Laserthermia Systems AB Files A New Patent Application for Expanded and Extended Protection of the Company's Technology for Laser-Based Tissue Ablation Until 2044
Clinical Laserthermia Systems Prices Warrants; Stock Falls
Clinical Laserthermia Systems AB Future-Proofs its Core Technology for MRI-Guided Laser Ablation in A New Agreement with Image Guided Therapy SA
Clinical Laserthermia Systems Obtains Marketing Approval for Tranberg Thermal Therapy Portfolio in Singapore
Clinical Laserthermia Systems AB Receives Market Approval for Its TRANBERG Portfolio by HSA in Singapore and Initiates the Process of Commercialization in the Region
Clinical Laserthermia Systems Gets SEK8 Million Order from ClearPoint Neuro; Stocks Rise
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CLS B Stock
  4. News Clinical Laserthermia Systems AB
  5. Other languages